RNA Therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
48
NCT07163325
EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 24, 2025
Completion: Nov 30, 2028
Loading map...